Cinctive Capital Management
DAWN icon

Cinctive Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Cinctive Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-450,000
Closed -$9.6M – 459
2026
Q1 		$9.6M Buy
+450,000
New +$6.34M 0.63% 39

Other funds holding DAWN

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Cinctive Capital Management's DAWN Position: Q2 2026 in Review

Cinctive Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 450,000 shares — an estimated $9.6M sold.

Cinctive Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $9.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Cinctive Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 450,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $9.6M.
  • Cinctive Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Cinctive Capital Management's Day One Biopharmaceuticals position peaked at $9.6M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.